Inventor · disambiguated record
Donald W. Kufe
Also filed as: KUFE DONALD · KUFE DONALD W
60 granted patents·49 pending applications·1,017 citations·filing 1988–2023
99Inventor score
Top patents by PatentIndex Score
109 records- 0194US7070968B2DNA damaging agents in combination with tyrosine kinase inhibitorsDANA FARBER CANCER INST INC·Filed 2003·Granted Jul 4, 2006·35 cites·25 claims
- 0294US6524832B1DNA damaging agents in combination with tyrosine kinase inhibitorsARCH DEV CORP·Filed 1994·Granted Feb 25, 2003·103 cites·9 claims
- 0392US5053489AGenetically engineered polypeptides with determinants of the human DF3 breast carcinoma-associated antigenDANA FARBER CANCER INST INC·Filed 1989·Granted Oct 1, 1991·80 cites·7 claims
- 0492US4963484AGenetically engineered polypeptides with determinants of the human DF3 breast carcinoma-associated antigenDANA FARBER CANCER INST INC·Filed 1988·Granted Oct 16, 1990·88 cites·10 claims
- 0591US5770581AGene transcription and ionizing radiation: methods and compositionsARCH DEV CORP·Filed 1995·Granted Jun 23, 1998·74 cites·15 claims
- 0691US5612318AControl of gene expression by ionizing radiationFiled 1994·Granted Mar 18, 1997·76 cites·8 claims
- 0790US7247297B2Use of DF3/MUC1 regulated expression in gene therapyDANA FARBER CANCER INST INC·Filed 2002·Granted Jul 24, 2007·30 cites·2 claims
- 0890US5571797AMethod of inducing gene expression by ionizing radiationARCH DEV CORP·Filed 1994·Granted Nov 5, 1996·87 cites·16 claims
- 0988US11136410B2Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)DANA FARBER CANCER INST INC·Filed 2018·Granted Oct 5, 2021·2 cites·4 claims
- 1088US7118738B2Recombinant pox virus for immunization against MUC1 tumor-associated antigenUS HEALTH·Filed 2002·Granted Oct 10, 2006·23 cites·37 claims
- 1187US7838512B2DNA damaging agents in combination with tyrosine kinase inhibitorsARCH DEV CORP·Filed 2006·Granted Nov 23, 2010·2 cites·7 claims
- 1286US7556935B2Induction of apoptosis by cellular stressDANA FARBER CANCER INST INC·Filed 2006·Granted Jul 7, 2009·9 cites·17 claims
- 1385US8524669B2MUC-1 cytoplasmic domain peptides as inhibitors of cancerKUFE DONALD W·Filed 2009·Granted Sep 3, 2013·6 cites·26 claims
- 1483US9546201B2MUC-1 cytoplasmic domain peptides as inhibitors of cancerDANA FARBER CANCER INST INC·Filed 2015·Granted Jan 17, 2017·3 cites·20 claims
- 1583US5506343AAntibodies specific for the DF3 carcinoma associated antigenDANA FARBER CANCER INST INC·Filed 1994·Granted Apr 9, 1996·64 cites·24 claims
- 1681US6652848B1Dendritic cell hybridsDANA FARBER CANCER INST INC·Filed 2000·Granted Nov 25, 2003·24 cites·18 claims
- 1780US8017315B2Mitochondrial localization of MUC1DANA FARBER CANCER INST INC·Filed 2006·Granted Sep 13, 2011·2 cites·7 claims
- 1880US7041653B2Gene transcription and ionizing radiation: methods and compositionsDANA FARBER CANCER INST INC·Filed 2000·Granted May 9, 2006·4 cites·16 claims
- 1979US10059775B2Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)DANA FARBER CANCER INST INC·Filed 2015·Granted Aug 28, 2018·2 cites·25 claims
- 2079US6156736AGene transcription and ionizing radiation: methods and compositionsARCH DEV CORP·Filed 1998·Granted Dec 5, 2000·21 cites·41 claims
- 2179US5676978AMethods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agentAMIRA INC·Filed 1994·Granted Oct 14, 1997·48 cites·65 claims
- 2277US12466895B2Antibodies against the MUC1-c/extracellular domain (MUC1-C/ECD)DANA FARBER CANCER INST INC·Filed 2021·Granted Nov 11, 2025·0 cites·29 claims
- 2377US10617773B2Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)DANA FARBER CANCER INST INC·Filed 2017·Granted Apr 14, 2020·1 cites·16 claims
- 2477US8685928B2Antagonists of MUC1KUFE DONALD W·Filed 2011·Granted Apr 1, 2014·1 cites·27 claims
- 2577US8614186B2Inhibition of inflammation using antagonists of MUC1KUFE DONALD W·Filed 2010·Granted Dec 24, 2013·3 cites·27 claims
- 2677US7931904B2Modulation of MUC1 activityDANA FARBER CANCER INST INC·Filed 2006·Granted Apr 26, 2011·1 cites·8 claims
- 2777US7601342B2Cell fusions and methods of making and using the sameDANA FARBER CANCER INST INC·Filed 2007·Granted Oct 13, 2009·1 cites·16 claims
- 2876US7118862B2Induction of apoptosis by cellular stressUNIV CHICAGO·Filed 2002·Granted Oct 10, 2006·11 cites·19 claims
- 2974US5565334AEnhancer sequence for modulating expression in epithelial cellsDANA FARBER CANCER INST INC·Filed 1994·Granted Oct 15, 1996·40 cites·25 claims
- 3073US7745109B2Regulation of cell growth by MUC1DANA FARBER CANCER INSITUTE IN·Filed 2003·Granted Jun 29, 2010·3 cites·23 claims
- 3173US6605712B1Gene transcription and ionizing radiation: methods and compositionsARCH DEV CORP·Filed 1992·Granted Aug 12, 2003·25 cites·35 claims
- 3273US2009232812A1Muc1 extracellular domain and cancer treatment compositions and methods derived therefromKUFE DONALD W·Filed 2009·Application pending·0 cites
- 3371US9096687B2Inhibition of inflammation using antagonists of MUC1DANA FARBER CANCER INST INC·Filed 2013·Granted Aug 4, 2015·1 cites·40 claims
- 3471US8957185B2MUC-1 cytoplasmic domain peptides as inhibitors of cancerKUFE DONALD W·Filed 2012·Granted Feb 17, 2015·1 cites·15 claims
- 3571US8318756B2Methods for administering DPD inhibitors in combination with 5-FU and 5-FU prodrugsSPECTOR THOMAS·Filed 2005·Granted Nov 27, 2012·2 cites·38 claims
- 3671US8034791B2Activation of Egr-1 promoter by DNA damaging chemotherapeuticsUNIV CHICAGO·Filed 2006·Granted Oct 11, 2011·1 cites·33 claims
- 3770US2025354144A1Targeting muc1-c with a novel antisense oligonucleotide for the treatment of cancerDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 3869US6426351B1Chelerythrine-based therapies for cancerDANA FARBER CANCER INC·Filed 2000·Granted Jul 30, 2002·8 cites·30 claims
- 3969US5874415AEnhancer sequence for modulating expression in epithelial cellsDANA FARBER CANCER INST INC·Filed 1995·Granted Feb 23, 1999·25 cites·20 claims
- 4068US8129506B2Modulation of the interaction of MUC1 with MUC1 ligandsKHARBANDA SURENDER·Filed 2004·Granted Mar 6, 2012·3 cites·14 claims
- 4168US5817636AControl of gene expression by ionizing radiationARCH DEV CORP·Filed 1995·Granted Oct 6, 1998·21 cites·32 claims
- 4267US8952054B2Small molecule inhibitors of MUC1 and methods of identifying the sameKUFE DONALD W·Filed 2011·Granted Feb 10, 2015·1 cites·22 claims
- 4367US8420591B2MUC1 and galectin-3KUFE DONALD W·Filed 2007·Granted Apr 16, 2013·1 cites·2 claims
- 4467US5641755ARegulation of x-ray mediated gene expressionARCH DEV CORP·Filed 1994·Granted Jun 24, 1997·31 cites·4 claims
- 4566US2013164811A1Dna damaging agents in combination with tyrosine kinase inhibitorsKUFE DONALD·Filed 2012·Application pending·0 cites
- 4665US6589981B2Tumor radiosensitization and/or chemopotentiation using isocoumarin derivativesILEX ONCOLOGY INC·Filed 2001·Granted Jul 8, 2003·3 cites·4 claims
- 4764US9663562B2Compositions and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2014·Granted May 30, 2017·0 cites·20 claims
- 4864US7919310B2Constitutive gene expression in conjunction with ionizing radiationUNIV CHICAGO·Filed 2008·Granted Apr 5, 2011·0 cites·4 claims
- 4962US2011053240A1Dna damaging agents in combination with tyrosine kinase inhibitorsARCH DEV CORP·Filed 2010·Application pending·0 cites
- 5061US6420335B1Combination of radiotherapy and anti-angiogenic factorsDANA FARBER CANCER INST INC·Filed 1999·Granted Jul 16, 2002·20 cites·28 claims
Showing the top 50 of 109 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →